Q4 2019 Holdings
Filed 2020-02-13 | 6 holdings | $233.3K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2020-05-20) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $87.5K | 3,940,543 | 37.5% |
| Precision Biosciences Inc | COM | 74019P108 | $59.2K | 4,265,141 | 25.4% |
| Turning Point Therapeutics I | COM | 90041T108 | $44.1K | 708,233 | 18.9% |
| Apellis Pharmaceuticals Inc(APLS)A | COM | 03753U106 | $30.6K | 1,000,000 | 13.1% |
| Apellis Pharmaceuticals, Inc | COM | 037530106 | $30.6K | 1,000,000 | 13.1% |
| Menlo Therapeutics Inc | COM | 586858102 | $6.8K | 1,461,552 | 2.9% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $5.0K | 875,000 | 2.2% |